Current Research Studies

A Phase 3, multicenter, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hidradenitis suppurativa

VELA-OLE

  • Condition(s): Other
  • Phase: III
  • Clinicaltrials.gov ID: NCT07007637

What is the goal of the study?

This is a Phase 3, multicenter, OLE study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe HS who were previously enrolled in a parental study.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: